Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
Gıancarlo Comı(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Mads Ravnborg(Odense University Hospital), Sámuel Komoly(University of Pecs), Adriana Carrá(Hospital Británico de Buenos Aires), Irina Elovaara(Tampere University), Jan Hillert, Catherine Lubetzki(Centre National de la Recherche Scientifique), Franz Fazekas(Medical University of Graz), Daniel Wynn(Consultants in Neurology), HP Hartung(Heinrich Heine University Düsseldorf), Carolyn Young(University of Liverpool), Ovidiu Băjenaru(Carol Davila University of Medicine and Pharmacy), M. Rodegher(Vita-Salute San Raffaele University), John King(The Royal Melbourne Hospital), K-M Myhr(Haukeland University Hospital), Lucia Moiola(Vita-Salute San Raffaele University)
Cited by 587
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k